General Vaginal Cancer News
The daily vaginal cancer news is a unique cancer news service that evaluates all aspects of vaginal cancer research and reports on the developments that are most important to cancer patients and health care providers. The daily cancer news provides information about emerging options for vaginal cancer prevention, early detection and vaginal cancer treatment, as well as advances in supportive care and personalized medicine. Supportive care improves quality of life by making vaginal cancer treatment more tolerable, and personalized medicine offers the potential for improved treatment outcomes by using specific characteristics of the patient or the cancer to guide cancer treatment decisions. In addition, interested individuals can search the Cancer Consultants Vaginal Cancer News Archives to find the results of the cancer studies that led to the care they have been offered.
Recent General Vaginal Cancer News
Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)
A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing... Continue Reading
According to a study published in the New England Journal of Medicine, women exposed to diethylstilbestrol (DES) before birth have an increased risk of vaginal cancer, cervical precancers, and breast cancer.... Continue Reading
People who are at high risk of cancer as a result of their family history may be advised to undergo earlier or more intensive cancer screening. Because family history of cancer can change over time, it’s... Continue Reading
Results from a randomized Phase III study indicate that whole-brain radiation therapy (WBRT) following removal of one to three brain metastases with surgery or radiosurgery does not improve overall survival... Continue Reading
Tumor burden in the sentinel node of early-stage vulvar cancer patients appears to be an important prognostic factor. Patients with sentinel-node metastasis larger than 2mm may have a worse prognosis. ... Continue Reading
Gardasil® Approved for Prevention of Vaginal and Vulvar Cancers The United States Food and Drug Administration (FDA) has expanded the indication for Gardasil® (Quadrivalent Human Papillomavirus [Types... Continue Reading
Updates in the Management of Gynecologic Cancers: A Report from the 39th Annual Meeting of the Society of Gynecologic Oncologists The 39th Annual Meeting of the Society of Gynecologic Oncologists (SGO)... Continue Reading
A recently published study in the New England Journal of Medicine reports that topical Aldara™ (imiquimod) may be an effective alternative to surgery for the treatment of precancerous changes to the... Continue Reading
Gardasil® Reduces Risk of Precancerous Changes to Vagina and Vulva According to the results of a study published in The Lancet, use of Gardasil®-a vaccine against four types of human papillomavirus-may... Continue Reading
According to results presented at the 2006 annual meeting of the American Society of Clinical Oncology, Gardasil®-a recently approved vaccine intended to prevent cervical cancer, precancerous genital... Continue Reading
